Re: ZEN-3694 Single Agent Trial Status
in response to
by
posted on
Sep 17, 2017 09:28PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
I believe the last we heard from Zenith was BIO International June 20, 2017. However, they only posted slides that contained very little new info. The last webcast was 9 months ago.